Skip to main content

September 2015

 

 

academics

 

Clinical research courses

Walk in interview for Scientist B (Non-Medical), Junior Research Fellow in Regional Medical Research Centre

A walk-in-interview is proposed to be conducted on 16th Oct 2015 to fill up the posts/fellowshipon consolidated salary under projects, as detail below, at the Regional Medical Research Centre (ICMR), Dollygunj, Port Blair. Candidates who fulfil the requisite qualifications may appear for the walk-in-interview at this Centre at Dollugunj, Port Blair. The verification of original certificates would commence from 9.30 a.m. onwards. The verification of original certificates would commence from 9.30 a.m. onwards. They should also carry with them filled-in application as per the format which is downloadable from our website www.rmrc.res.in along with copies of all the certificates of educational qualifications, date of birth, working experience and affixing a passport size photograph, at the time of walk-in-interview. Candidates are also required to bring their original certificates for verification. No TA/DA will be paid for this purpose.

Post: Scientist B (Non-Medical), Junior Research Fellow

Vacancies for Lecturers in Tirupati College of Polytechnic & Pharmacy

The ethics of our institution is expressed in few words written above and is self illuminating, the institution work on the visualization that "We may never have the opportunity to do great things in a great way, but we all have the chance to do small things in a great way". The changing scenario of education has enhanced the enormity and importance of the task of college to educate the students such that it gives direction and perspective to their thoughts. The onus of inculcating scruples in the dynamic world where ethics have slipped into oblivion owing to Globalization, Liberalization and Westernization rests with educational institutions. It is sobering responsibility of an educational institution to train, develop the knowledge, mind and character of the students.

Post: Lecturers

Walk in interview for Research Assistant in Visva-Bharati (A Central University)

A study of the evolution of Visva-Bharati during the lifetime of its founder, Rabindranath Tagore, offers an insight into what this institution was intended to achieve. Rabindranath founded a school for children at Santiniketan and it was around this nucleus that the structure of an unconventional university developed through careful planning. In 1863, on a seven-acre plot at the site of the present institution, Debendranath Tagore, the poet's father, had built a small retreat for meditation, and in 1888 he dedicated, the land and buildings, towards establishment of a Brahmavidyalaya and a library. Rabindranath's school Brahmacharyasrama which started functioning formally from December 22, 1901 with no more than five students on the roll, was, in part, a fulfilment of the wishes of his father who was a considerable figure of his time in the field of educational reforms. From 1925 this school came to be known as Patha-Bhavana.

Post: Research Assistant

Work as Manager- Clinical Research/Medical Monitor in Panacea Biotec

Panacea Biotec is a leading research based Health Management Company. We are engaged in research, development, manufacture & marketing of Vaccines, Bio-Pharmaceuticals and Pharmaceuticals (Rx & OTC) of international quality and Health Services. All Panacea Biotec plants are accredited by international agencies and they follow current Good Manufacturing Practices, as per WHO guidelines.

We offer stimulating work environment & a career that spells growth. In tune with our plans, we require young, aggressive, dynamic, high performing and result oriented professional.

Post: Manager- Clinical Research/Medical Monitor

TOMATO CUISINES: A DELECTABLE REJOINDER TO THREAT OF CHRONIC AILMENTS?

{ DOWNLOAD AS PDF }

ABOUT AUTHORS:
Vikram S. Chauhan1*, Bina Rani2, Priyanka Bishnoi3, Raaz K. Maheshwari3

1
Department of Botany, SBRM Govt PG College, Nagaur, Rajasthan, India
2Department of Engineering chemistry & Environmental Engineering, Poornima College of Engineering, Jaipur, India
3Department of Chemistry, SBRM Government PG College, Nagaur, Rajasthan, India
*vikkysingh2000@yahoo.com; rkmgreenchem.jaipur@gmail.com

ABSTRACT
With the advent of modern times, stress and pollution have led to major effect on rise of death toll due to chronic diseases. Such diseases are major cause of concern for the medical society. Lycopene, a carotenoid pigment found in tomatoes and its products has antioxidant properties due to the presence of numerous double bonds. Increased consumption of lycopene containing diet has been proposed to offer a protection against many types of cancers and cardio-vascular diseases. Its potential role as nutraceutical has been suggested in many studies. The present review deals with fundamental biochemistry, bio-availability and benefits of lycopene rich diet and its relation with some chronic diseases like various forms of cancers and cardiovascular diseases.

Walk in for Fresher M.Pharm candidates as Associate Research Analyst in Thomson Reuters

Thomson Reuters is the leading source of intelligent information for the world's businesses and professionals, providing customers with competitive advantage. Intelligent information is a unique synthesis of human intelligence, industry expertise and innovative technology that provides decision-makers with the knowledge to act, enabling them to make better decisions faster. Through its more than 50,000 people across 93 countries, Thomson Reuters delivers this must-have insight to the financial, legal, tax and accounting, scientific, healthcare and media markets, and is powered by the world's most trusted news organization.

Post: Associate Research Analyst

Walk in for Pharmacist in N.H.M. Program, District Health Society, Valsad | 7 Posts

Walk in Interview for below mention posts on contractual bases under N.H.M. Program, District Health Society, Valsad

Post: Pharmacist

U.S. Food and Drug Administration (FDA) has accepted BMS's filing and review a supplemental Biologics License Application (sBLA) for the Opdivo (nivolumab)+Yervoy (ipilimumab) regimen to include clinical data from CheckMate -067, a landmark trial in patients with previously untreated advanced melanoma. The FDA also granted Priority Review for this application with a target action date of January 23, 2016.

Bristol-Myers Squibb Company (BMS) and Moffitt Cancer Center today announced that they have entered into a collaboration agreement as part of Bristol-Myers Squibb’s Immuno-Oncology Rare Population Malignancy (I-O RPM) program in the U.S. The I-O RPM program is a multi-institutional initiative with academic-based cancer centers focused on the clinical investigation of immuno-oncology therapeutics as potential treatment options for patients with high risk, poor prognostic cancers, defined as a rare population malignancy.

  • GBR 1302, a HER2xCD3 bi-specific antibody has successfully completed the  preclinical  evaluation phase
  • Preclinically, GBR 1302 has demonstrated superiority over current antibody therapies against most HER2 positive cancers, including breast cancer
  • The phase 1 trial application for this antibody has been submitted  to  German regulatory  authorities.
  • GBR  1302  has the potential  to  be  used  in  the  treatment a  broad  array  of  cancers  in cluding breast cancer
  • If  confirmed  in  clinical  trials,  GBR  1302  could  constitute an innovative treatment for HER2 positive cancers, potentially  superior  to the currently available  monoclonal  antibody treatments